Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis.. Gastroenferal Clin North Am 2003; 32: 877-889.
de Boissieu D, Knisely AS. Neonatal hemochromatosis. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver disease in children. Philadelphia: Lippincott. Williams and Wilkins, 2001: 641-647.
Goldfischer S, GrotskyHW, Chang CH, et al. Idiopathic neonatal iron storage involving the liver, pancreas, heart, and endocrine and exocrine glands.. Hepatology 1981; 1: 58-64.
Silver MM, Beverley DW, Valberg LS, Cutz E, Phillips MJ, Shaheed WA. Perinatal hemochromatosis: clinical, morphologic, and quantitative iron studies.. Am J Patlioll987: 128: 538-554.
Metzman R, Anand A, DeGiulio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. JPediatr Gastroenterol Nutr 1989: 9: 112-114.
Collins J, Goldfischer S. Perinatal hemochromatosis: one disease, several diseases or a spectrum?. Hepatology 1990; 12:176-177.
Ruchelli ED, Uri A, Dimmick JE, et al. Severe perinatal liver disease and Down syndrome: an apparent relationship. Hum Pathol 1991; 22: 1274-1280.
Taucher SC, Bentjerodt R, Hubner ME, Nazer J. Multiple malformations in neonatal hemochromatosis. Am J Med Genet 1994: 50: 213-214.
ShneiderBL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis.. JPediatr 1994; 124: 234-238.
Verloes A, Lombet J, Lambert Y, et al. Tricho-hepato-enteric syndrome: further delineation of a distinct syndrome with neonatal hemochromatosis phenotype, intractable diarrhea, and hair anomalies. Am J Med Genet 1997;68:391-395.
Witzleben CL. Yri A. Perinatal hemochromatosis: entity or end result? Hum Pathol 1989;20:335-340.
Hoogstraten J, de Sa DJ, Knisely AS. Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis.. Gastroenterology 1990; 98: 1699- 1701.
Kelly AL, Lunt PW, Rodrigues F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001:38:599-610.
Cox TM, Halsall DJ. Hemochromatosis: neonatal and young subjects. Blood Cells MolDis 2002; 29: 411-417.
Ferrell L, Schmidt K, Sheffield V, Packman S. Neonatal hemochromatosis: genetic counseling based on retrospective pathologic diagnosis.. Am J Med Genet 1992; 44: 429-433.
Sheider BL, Genetic counseling in neonatal hemoehromatosis. J Pediatr Gastroenterol Nutr 2002; 34: 328.
Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemoehromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child 1993; 147: 1072-1075.
Kaplan C, Forestier F, Daftbs F, Tchernia G, Waters A. Management of fetal and neonatal alloimmune thrombocytopenia. Transfiis Med Rev1996;10:233-240.
Allen K, Whitington PF. Evaluation of liver function. In: Pol in R, Fox W, eds. Fetal and neonatal physiology. Philadelphia: WB Saunders. 1998: 1530-1552.
Powell LW, George DK. McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129: 925-931.
Berlin G, Selbing A, Ryden G, Rhesus haemolytic disease treated with figh-dose intravenous immunoglobulin. Lancet 1985;1:1153.
Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia: detection of IgE antibodies to IgA. N Engl J Med 1986;314:560-564.
Kaatrchkine MD, Kaveri SV. Immunodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-755.
Obiekwe BC, Malk N, Kitau MJ Chard T, Maternal and fetal alphafetoprotein (AFP) levels at term: relation to sex, weight and gestation of the infant. Acta Obstet Gynecol Scand 1985;64:251-253.
Gitlin D. NMormal biology of alpha-fetoprotein. Ann NY Acad Sci 1975;259:7-16.
Allen K, Whitington PF. Evaluation of liver function. In: Polin R, Fox W, eds. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1998:1530-1552.
Powel LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Inter Med 1998;129:925-931.
Shamieh I, Kibort PK, Suchy FJ, Freese DK. Antioxidant therapy for neonatal iron storage disease (NISD).. Pediatr Res 1993; 33: 109 A(abstr).
Branch DW, Porter TF, Paidas MJ, Belfort MA, Gonik B. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises. J Allergy Clin Immunol 2001; 108 (suppl): S133-S138
Elynn DM, Mohan N, McKieman P, et al. Progress in treatment and outcome for children with neonatal haemochromatosis.. Arch Dis Child Fetal Neonatal Ed 2003; 88: F124-F127.
Shneider BL. Neonatal liver failure. Curr Opin Pediatr 1996; 8: 495-501.
Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J. Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998; 26: 85-89.
Vohra P, Haller C, Em re S, et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pedialr 2000; 136: 537-541.
Debiec H, Guigonis V, Mougenot B, et a!. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.. Ν Engl JMed 2002; 346: 2053-2060.
Riemersma S, Vincent A, Beeson D, et al. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.. J Clin Invest 1996; 98: 2358-2363.
Rothenberg SP, da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. NEnglJMed 2004; 350: 134-142.
da Costa M, Sequeira JM, Rothenberg SP, WeedonJ. Antibodies to folate receptors impair embryogenesis and fetal development in the rat.. Birth Defects Res Part A Clin Mo I Teratol 2003; 67: 837-847.
Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (US.F2) knockout mice.. Proc Nail Acad Sci USA 2001; 98: 8780-8785.
Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transpl 2003; 9: 783-788.
Sekul EA. Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors.. Ann Intern Med 1994; 121: 259-262.
Bagdasarian A, Tonetta S, Hard W, Mamidi R, Uemura Y. IVIG adverse reactions: potential role of cytokines and vasoactive substances.. Vox Sang 998; 74: 74-82.
Farquharson, R. G., Jauniaux, E., Exalto, N., on behalf of the ESHRE Special Interest Group for, (2005). Updated and revised nomenclature for description of early pregnancy events. HumReprod20: 3008-3011 [Abstract] [Full Text]
Bertolaccini, Μ L, Gomez, S, Pareja, J F P, Theodoridou, A, Sanna, G, Hughes, G R V, Khamashta, Μ A (2005). Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis 64: 1639-1643 [Abstract] [Full Text]
Presotto, F., Fornasini, F., Betterle, C., Federspil, G., Rossato, M. (2005). Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature, eurj endocrinol 153: 507-514 [Abstract] [Full Text]
Fischetti, F., Durigutto, P., Pellis, V., Debeus, A., Macor, P., Bulla, R., Bossi, F., Ziller, F., Sblattero, D., Meroni, P., Tedesco, F. (2005). Thrombus formation induced by antibodies to {beta}2-glycoprotein I is complement dependent and requires a priming factor. Blood 106:2340-2346 [Abstract] [Full Text]
Krause, I, Lev, S, Fraser, A, Blank, M, Lorber, M, Stojanovich, L, Rovensky, J, Chapman, J, Shoenfeld, Υ (2005). Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis 64: 1490-1493 Abstract] (Full Text]
RUIZ-IRASTORZA, G, KHAMASHTA, M.A. (2005). Management of Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Pregnancy. Annals NYAS Online 1051: 606-612 [Abstract] [Full Text]
MEDINA, G., VERA-LASTRA, O., ANGELES, U., JARA, L. J. (2005). Mono-organic versus Multi-organic Involvement in Primary Antiphospholipid Syndrome. Annals NYAS Online 1051: 304-312 [Abstract] [Full Text]
Safa, O., Esmon, C. T., Esmon, N. L. (2005). Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies. Blood 106: 1629-1635 [Abstract] [Full Text]
Massoudy, P., Cetin, S. M., Thielmann, M., Kienbaum, P., Piotrowski, J. A., Marggraf, G., Specker, C., Jakob, H. (2005). Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder?. Eur JCardiofhorac Surg 28: 133-137 [Abstract] [Full Text]
Gaburri, Ρ D, Chebli, J M F, Attalla, A, Pereira, C M N, Bonfante, Η L, Martins Junior, Ε V, Gaburri, A K (2005). Colonic ulcers in propylthiouracil induced vasculitis with secondary antiphospholipid syndrome. PostgradMed J 81: 338-340 [Abstract] [Full Text]
Andreotti, F., Becker, R. C. (2005). Atherothrombotic Disorders: New Insights From Hematology. Circulation 111: 1855-1863 [Full Text]
Simoncini, S., Sapet, C., Camoin-Jau, L., Bardin, N., Harle, J.-R., Sarnpol, J., Dignat-George, F., Anfosso, F. (2005). Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome. Int Immunol 17: 489-500 [Abstract] [Full Text]
Ferreira, S., D'Cruz, D. P., Hughes, G. R. V. (2005). Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?. Rheumatology 44: 434-442[Abstract] [Full Text]
Zhang, J., McCrae, K. R. (2005). Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-{beta}2 glycoprotein I antibodies. Blood 105: 1964-1969 [Abstract] [Full Text]
Di Simone, N, Raschi, E, Testoni, C, Castellani, R, D'Asta, M, Shi, T, Krilis, S A, Caruso, A, Meroni, Ρ L (2005). Pathogenic role of anti-{beta}2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of {beta}2-glycoprotein I binding to trophoblast cells and functional effects of anti-{beta}2-glycoprotein I antibodies in vitro. Ann Rheum Dis 64: 462-467 [Abstract] [Full Text]
de Laat, B., Derksen, R. H. W. M., Urbanus, R. T., de Groot, P. G. (2005). IgG antibodies that recognize epitope Gly40-Arg43 in domain I of {beta}2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105: 1540-1545 [Abstract] [Full Text] LaBerge, J. M., Kerlan, R. K., Schneider, D. B., Gordon, R. L. (2005). Extensive Peripheral, Iliofemoral, and Caval Thrombosis in a 16-Year-Old Girl. J Vase Interv Radial 16: 133-137